Will FTC Challenge Product Switching In Obama Administration?

 
• By Brenda Sandburg

Lawyers are wary that the Federal Trade Commission may take a more aggressive stance toward pharmaceutical industry practices in the Obama administration

More from Archive

More from Pink Sheet